Revolution Medicines, Inc. (RVMD) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 742K | 0 | 3.82M |
| Revenue Growth % | - | - | - | - | - | -100% | - | -100% | -100% | -95.16% | -100% | -58.05% |
| Cost of Goods Sold | 0 | 4.7M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 0 | -4.7M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 742K | 0 | 3.82M |
| Gross Margin % | - | - | - | - | - | - | - | - | - | 100% | - | 100% |
| Gross Profit Growth % | - | - | - | - | - | -100% | - | -100% | -100% | -95.16% | -100% | -58.05% |
| Operating Expenses | 445.22M | 356.92M | 315.27M | 264.71M | 240.76M | 216.31M | 175.71M | 156.64M | 140.86M | 180.72M | 123.25M | 112.62M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | 24356.47% | - | 2945.11% |
| Selling, General & Admin | 101.25M | 64.32M | 52.76M | 40.58M | 35.01M | 28.21M | 23.96M | 21.71M | 22.84M | 32.24M | 15.51M | 14.64M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | 4345.55% | - | 382.85% |
| Research & Development | 343.97M | 292.61M | 262.51M | 224.13M | 205.75M | 188.1M | 151.75M | 134.93M | 118.02M | 148.48M | 107.73M | 97.98M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | 20010.92% | - | 2562.26% |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -445.22M | -361.63M | -315.27M | -264.71M | -240.76M | -216.31M | -175.71M | -156.64M | -140.86M | -179.98M | -123.25M | -108.8M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | -24256.47% | - | -2845.11% |
| Operating Income Growth % | -84.92% | -67.18% | -79.42% | -68.99% | -70.92% | -20.18% | -42.57% | -43.98% | -87.42% | -191.67% | -61.04% | -75.23% |
| EBITDA | -445.22M | -356.92M | -310.93M | -260.91M | -237.04M | -212.92M | -172.84M | -153.85M | -138.1M | -177.13M | -121.1M | -107.02M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | -23871.29% | - | -2798.74% |
| EBITDA Growth % | -87.82% | -67.63% | -79.9% | -69.59% | -71.65% | -20.21% | -42.72% | -43.75% | -90.15% | -199.66% | -63.43% | -79.1% |
| D&A (Non-Cash Add-back) | 0 | 4.7M | 4.34M | 3.8M | 3.72M | 3.39M | 2.88M | 2.8M | 2.76M | 2.86M | 2.15M | 1.77M |
| EBIT | 0 | -352.96M | -293.78M | -264.71M | -240.76M | -216.31M | -156.29M | -156.64M | -140.86M | -132.39M | -123.25M | -108.8M |
| Net Interest Income | 0 | 9.36M | 10.65M | 22.4M | 24.91M | 21.23M | 20.41M | 21.49M | 23.76M | 18.67M | 10.95M | 10.5M |
| Interest Income | 19.51M | 21.29M | 22.08M | 22.4M | 24.91M | 21.23M | 20.41M | 21.49M | 23.76M | 18.67M | 10.95M | 10.5M |
| Interest Expense | -12.2M | 11.94M | 11.43M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | -8.59M | -3.27M | 10.06M | 16.93M | 27.34M | 20.99M | 19.42M | 23.41M | 24.86M | 18.79M | 10.95M | 10.5M |
| Pretax Income | -453.82M | -364.89M | -305.21M | -247.79M | -213.42M | -195.32M | -156.29M | -133.23M | -116M | -161.19M | -112.3M | -98.3M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | -21724.26% | - | -2570.55% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | -753K | 0 | 0 | 0 | 343K | -3.87M | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0.39% | 0% | 0% | 0% | -0.21% | 3.44% | 0% |
| Net Income | -453.82M | -364.89M | -305.21M | -247.79M | -213.42M | -194.57M | -156.29M | -133.23M | -116M | -161.54M | -108.43M | -98.3M |
| Net Margin % | - | - | - | - | - | - | - | - | - | -21770.49% | - | -2570.55% |
| Net Income Growth % | -112.64% | -87.54% | -95.28% | -85.98% | -83.97% | -20.45% | -44.13% | -35.54% | -70.35% | -185.87% | -47.87% | -60.56% |
| Net Income (Continuing) | -453.82M | -364.89M | -305.21M | -247.79M | -213.42M | -194.57M | -156.29M | -133.23M | -116M | -161.54M | -108.43M | -98.3M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -2.29 | -1.90 | -1.61 | -1.31 | -1.13 | -1.13 | -0.94 | -0.81 | -0.70 | -1.14 | -0.99 | -0.92 |
| EPS Growth % | -102.65% | -68.14% | -71.28% | -61.73% | -61.43% | 0.88% | 5.05% | 11.96% | -12.9% | -80.95% | -13.79% | -13.58% |
| EPS (Basic) | -2.29 | -1.90 | -1.61 | -1.31 | -1.13 | -1.13 | -0.94 | -0.81 | -0.70 | -1.14 | -0.99 | -0.92 |
| Diluted Shares Outstanding | 198.1M | 190.13M | 189.23M | 188.15M | 188.15M | 167.74M | 166.84M | 165.14M | 164.73M | 141.18M | 109.23M | 106.88M |
| Basic Shares Outstanding | 198.1M | 190.13M | 189.23M | 188.15M | 188.15M | 167.74M | 166.84M | 165.14M | 164.73M | 141.18M | 109.23M | 106.88M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |